Back to results
US 8,557,835 B2Granted
Statin-carboxyalkylether combinations
AssigneeWarner-Lambert Company
InventorsCharles Larry Bisgaier, Roger Schofield Newton
Life of this patent
Estimating the term…
Abstract
The invention is a pharmaceutical composition comprising a carboxyalkylether which lowers triglycerides and elevated HDL, and a statin which inhibits HMG-CoA reductase, thereby reducing LDL, said composition being useful for treating vascular diseases.
Claims11
A pharmaceutical composition comprising:
- a. 6,6′-oxybis(2,2-dimethylhexanoic acid) or a pharmaceutically acceptable acid addition salt thereof;
- b. an amount of a statin or a pharmaceutically acceptable salt thereof;
- and
- c. a pharmaceutically acceptable carrier or diluent.
1 more element
A method of treating a condition wherein the condition is hyperlipidemia, angina pectoris, atherosclerosis, or is a condition characterized by the presence of both hypertension and hyperlipidemia comprising
- (a) administering to a patient in need thereof an effective amount of 6,6′-oxybis(2,2-dimethylhexanoic acid) or a pharmaceutically acceptable acid addition salt thereof;
- and
- (b) administering to the patient an amount of a statin or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.